Inventor · disambiguated record
Maxime Lampilas
Also filed as: LAMPILAS MAXIME
16 granted patents·6 pending applications·365 citations·filing 2001–2012
93Inventor score
Top patents by PatentIndex Score
22 records- 0196US7112592B2Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agentsAVENTIS PHARMA SA·Filed 2001·Granted Sep 26, 2006·103 cites·22 claims
- 0295US7612087B2Heterocyclic compounds as inhibitors of beta-lactamasesNOVEXEL·Filed 2004·Granted Nov 3, 2009·93 cites·16 claims
- 0394US7732610B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agentsAVENTIS PHARMA SA·Filed 2006·Granted Jun 8, 2010·29 cites·7 claims
- 0493US8178554B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agentsLAMPILAS MAXIME·Filed 2011·Granted May 15, 2012·25 cites·6 claims
- 0593US7638529B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agentsAVENTIS PHARMA SA·Filed 2005·Granted Dec 29, 2009·21 cites·19 claims
- 0691US7439253B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitorsNOVEXEL·Filed 2003·Granted Oct 21, 2008·57 cites·23 claims
- 0787US7288549B2Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agentsAVENTIS PHARMA SA·Filed 2002·Granted Oct 30, 2007·26 cites·10 claims
- 0883US8148540B2Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agentsASZODI JOSEPH·Filed 2007·Granted Apr 3, 2012·9 cites·4 claims
- 0975US7399770B2Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitorsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Jul 15, 2008·2 cites·5 claims
- 1067US8119813B2Method for preparing enantiomerically enriched N-carboxyanhydrideBIGOT ANTONY·Filed 2009·Granted Feb 21, 2012·0 cites·22 claims
- 1166US2010048528A1Heterocyclic compounds as inhibitors of beta-lactamasesNOVEXEL·Filed 2009·Application pending·0 cites
- 1266US2009215747A1Heterocyclic compounds as inhibitors of beta-lactamasesAVENTIS PHARMA SA·Filed 2009·Application pending·0 cites
- 1361US8071788B2Method and intermediates for the preparation of derivatives of N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamideBOFFELLI PHILIPPE·Filed 2009·Granted Dec 6, 2011·0 cites·2 claims
- 1461US2009018329A1Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitorsNOVEXEL·Filed 2008·Application pending·0 cites
- 1559US7652154B2Method and intermediates for the preparation of derivatives of N (1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamideSANOFI AVENTIS·Filed 2008·Granted Jan 26, 2010·0 cites·4 claims
- 1657US7429668B2Method and intermediates for the preparation of derivatives of N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamideSANOFI AVENTIS·Filed 2007·Granted Sep 30, 2008·0 cites·7 claims
- 1755US2011245254A1Heterocyclic compounds as inhibitors of beta-lactamasesFOREST LAB HOLDINGS LTD·Filed 2011·Application pending·0 cites
- 1853US2011021772A1New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agentsAVENTIS PHARMA SA·Filed 2010·Application pending·0 cites
- 1952US2012215007A1Method for preparing enantiomerically enriched n-carboxyanhydrideBIGOT ANTONY·Filed 2012·Application pending·0 cites
- 2046US8067435B2Nitrogen-containing heterocyclic compounds, their preparation and their use as antibacterial drugsLAMPILAS MAXIME·Filed 2009·Granted Nov 29, 2011·0 cites·11 claims
- 2144US8063219B2Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicamentsLAMPILAS MAXIME·Filed 2008·Granted Nov 22, 2011·0 cites·20 claims
- 2231US8207355B2Method for preparing azetidine derivativesBIGOT ANTONY·Filed 2010·Granted Jun 26, 2012·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Maxime Lampilas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →